Immunotherapy through Extracorporeal Photochemotherapy
Program Code: 126-S
Saturday, October 15, 2005
2:00 PM to 3:30 PM (ET)

MODERATOR
Michael Girardi, MD, Yale University School of Medicine

SPEAKERS
Francine M. Foss, MD, Tuffs New England Medical Center
Michael Girardi, MD, Yale University School of Medicine
Richard Edelson, MD, Yale Cance Center

DESCRIPTION
Extracorporeal photochemotherapy (ECP), or “Photopheresis,” is a widely used treatment for cutaneous T-cell lymphoma (CTCL) and other T-cell mediated disorders. This session will review clinical trials of ECP in CTCL and GVHD, and evolving scientific understanding of ECP’s mechanism in the context of future exciting directions.